Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

biOasis Technologies Ord Shs V.BTI


Primary Symbol: V.BTI.H Alternate Symbol(s):  BIOAF

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.


TSXV:BTI.H - Post by User

Comment by jdstoxon Oct 14, 2017 12:35pm
185 Views
Post# 26813705

RE:RE:RE:Insider buying

RE:RE:RE:Insider buyingI just have to shake my head at the foolishness of digitel's post comparing a major investor like Rob McEwan to a corporate employee, or to a director, for that matter.

Companies, including Bioasis, require employees. Employees do the work. Since when do employees, people who work for somebody else, have tens or hundreds of thousands of dollars sitting around to invest in their new employer?

Using your logic, digitel, people shouldn't get a job unless they can buy into the company.

Which means they have to buy their jobs.

And that means the prospective employee's specialized field of knowledge and competence means less than how much money he can come up with to buy his job.

And that means that you think that tcompetence is measured by wealth.

And that means that you don't have any idea what you're talking about, digitel

What a bunch of nonsense!

I listened to the Rob McEwan interview - rant, more accurately. Good for him and all who sail upon him. Looks like the kind of guy you could learn something from if you didn't have to sit in his company and listen to him.

jdstox


Bullboard Posts